Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
296.28
-1.22 (-0.41%)
At close: Jul 28, 2026, 4:00 PM EDT
296.70
+0.42 (0.14%)
After-hours: Jul 28, 2026, 4:11 PM EDT
Ligand Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains $388 | Buy | Maintains | $388 | +30.96% | Jul 22, 2026 |
| Citi | Citi | Buy Initiates $387 | Buy | Initiates | $387 | +30.62% | Jul 21, 2026 |
| Benchmark Co. | Benchmark Co. | Buy Maintains $275 → $335 | Buy | Maintains | $275 → $335 | +13.07% | Jul 16, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $262 → $340 | Buy | Maintains | $262 → $340 | +14.76% | Jul 15, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $255 → $332 | Buy | Reiterates | $255 → $332 | +12.06% | Jul 8, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $289 | Buy | Reiterates | $289 | -2.46% | May 7, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $275 → $277 | Buy | Maintains | $275 → $277 | -6.51% | Feb 27, 2026 |